Strategies for elimination of rubella in pregnancy and of congenital rubella syndrome in high and upper-middle income countries
pdf

Keywords

Rubella
Vaccination
Congenital rubella syndrome
Surveillance
Coverage

Abstract

Rubella infection generally leads to mild symptoms; otherwise, in pregnant women it can cause severe damages. The only way to prevent rubella is vaccine. Before the introduction of the vaccine, up to 4 babies in 1000 live births were born with CRS.

This work aims to review the most important strategies for the elimination of CRS in upper and high-income countries.

Papers were selected through a PubMed search up to January 2019, using keywords rubella, congenital rubella syndrome and epidemiology. Articles published in the last 12 years and referred to upper income and high-income countries in title or abstract were included.

Sixty-five papers were selected dealing with one or more of the following strategies: increasing of rubella vaccination coverage in childbearing age women, males, immigrants; exploitation of all appropriate occasions; improving of rubella surveillance.

Despite numerous suggestions and indications for valid strategies to eliminate rubella in pregnancy and congenital rubella syndrome, a practical application is often missing.

https://doi.org/10.15167/2421-4248/jpmh2020.61.1.1310
pdf

References

Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA. Rubella. Lancet. 2015 Jun 6;385(9984):2297-307. doi:10.1016/S0140-6736(14)60539-0. PMID:25576992.

WHO Regional Office for Europe. Surveillance guidelines for measles, rubella and congenital rubella syndrome in the WHO European region. Update December 2012. Copenhagen; 2009. http://www.euro.who.int/__data/assets/pdf_file/0018/79020/e93035-2013.pdf?ua=1

Patel MK, Gibson R, Cohen A, Dumolard L, Gacic-Dobo M. Global landscape of measles and rubella surveillance. Vaccine. 2018 Nov 19;36(48):7385-7392 doi:10.1016/j.vaccine.2018.10.007. PMID: 30318167.

Grant GB, Reef SE, Patel M, Knapp JK, Dabbagh A. Progress in Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2000-2016. MMWR Morb Mortal Wkly Rep. 2017 Nov 17;66(45):1256-1260. doi:10.15585/mmwr.mm6645a4. PMID:29145358.

Eliminating measles and rubella and preventing congenital rubella infection. WHO European Region strategic plan 2005-2010. Copenhagen, WHO Regional Office for Europe, 2005.

http://www.euro.who.int/__data/assets/pdf_file/0008/79028/E87772.pdf

Bouthry E, Picone O, Hamdi G, Grangeot-Keros L, Ayoubi JM,

Vauloup-Fellous C. Rubella and pregnancy: diagnosis, management and outcomes. Prenat Diagn. 2014 Dec;34(13):1246-53. doi:10.1002/pd.4467. PMID:25066688.

Bonanni P, Bechini A, Boccalini S, Peruzzi M, Tiscione E, Boncompagni G, Mannelli F, Salmaso S, Filia A, Ciofi degli Atti M. Progress in Italy in control and elimination of measles and congenital rubella. Vaccine. 2007 Apr 20;25(16):3105-10.

doi:10.1016/j.vaccine.2007.01.019. PMID:17306425.

Gioula G, Fylaktou A, Exindari M, Atmatzidis G, Chatzidimitriou D, Melidou A, Kyriazopoulou-Dalaina V. Rubella immunity and vaccination coverage of the population of northern Greece in 2006. Euro Surveill. 2007 Nov 1;12(11):E9-10. PMID:18005657.

Jin L, Thomas B. Application of molecular and serological assays to case based investigations of rubella and congenital rubella syndrome. J Med Virol. 2007 Jul;79(7):1017-24. doi:10.1002/jmv.20847. PMID:17516526.

Rota MC, Bella A, Gabutti G, Giambi C, Filia A, Guido M, De Donno A, Crovari P, Ciofi Degli Atti ML; Serological Study Group. Rubella seroprofile of the Italian population: an 8-year comparison. Epidemiol Infect. 2007 May;135(4):555-62. doi:10.1017/S0950268806007400. PMID:17076939.

Carnicer-Pont D, Peña-Rey I, de Aragón VM, de Ory F, Dominguez A, Torner N, Caylà JA; Regional Surveillance Network. Eliminating congenital rubella syndrome in Spain: does massive immigration have any influence? Eur J Public Health. 2008 Dec;18(6):688-90. doi:10.1093/eurpub/ckn098. PMID:18927183.

Centers for Disease Control and Prevention (CDC). Progress toward elimination of rubella and congenital rubella syndrome--the Americas, 2003-2008. MMWR Morb Mortal Wkly Rep. 2008 Oct 31;57(43):1176-9. PMID:18971920.

Progress towards eliminating rubella and congenital rubella syndrome in the western hemisphere, 2003-2008. Wkly Epidemiol Rec. 2008 Oct 31;83(44):395-400. PMID:18975450.

Canepa P, Valle L, Cristina E, De Florentiis D, Parodi V, Banfi F, Zancolli M, Durando P, Icardi G, Ansaldi F. Role of congenital rubella reference laboratory: 21-months-surveillance in Liguria, Italy. J Prev Med Hyg. 2009 Dec;50(4):221-6. PMID:20812517.

Forsey JT, Elmasry OA, Martin RP. Patent arterial duct. Orphanet J Rare Dis. 2009 Jul 10;4:17. doi:10.1186/1750-1172-4-17. PMID:19591690.

Lugnér AK, Mollema L, Ruijs WL, Hahné SJ. A cost-utility analysis of antenatal screening to prevent congenital rubella syndrome. Epidemiol Infect. 2010 Aug;138(8):1172-84. doi: 10.1017/S0950268809991336. PMID:20018128.

Martin RM. Prevention of congenital rubella and congenital varicella in Europe. Euro Surveill. 2009 Apr 9;14(14):10; author reply 11. PMID:19371507.

McElroy R, Laskin M, Jiang D, Shah R, Ray JG. Rates of rubella immunity among immigrant and non-immigrant pregnant women. J Obstet Gynaecol Can. 2009 May;31(5):409-13. PMID:19604421.

Pandolfi E, Chiaradia G, Moncada M, Rava L, Tozzi AE. Prevention of congenital rubella and congenital varicella in Europe. Euro Surveill. 2009 Mar 5;14(9):16-20. PMID:19317971.

Bispo de Filippis AM, Icenogle J, Matus CR, Andrus JK. Enhanced laboratory surveillance for the elimination of rubella and congenital rubella syndrome in the Americas. J Infect Dis. 2011 Sep 1;204 Suppl 2:S652-8. doi:10.1093/infdis/jir405. PMID:21954262.

Castillo-Solórzano C, Marsigli C, Bravo-Alcántara P, Flannery B, Ruiz Matus C, Tambini G, Gross-Galiano S, Andrus JK. Elimination of rubella and congenital rubella syndrome in the Americas. J Infect Dis. 2011 Sep 1;204 Suppl 2:S571-8. doi:10.1093/infdis/jir472. PMID:21954249.

Gross-Galiano S. Rubella and congenital rubella syndrome elimination: lessons learned for the future. Preface. J Infect Dis. 2011 Sep 1;204 Suppl 2:ii. doi:10.1093/infdis/jir555. PMID:21954241.

Hernández Díaz R, Rodrigo Val MP, Misiego Peral A, Roc Alfaro ML, Adiego Sancho MB. [Seroepidemiologic study of rubella in childbearing women in Aragon, Spain (2003-2007)]. Gac Sanit. 2011 Jan-Feb;25(1):20-2. doi:10.1016/j.gaceta.2010.09.003. PMID:21074904.

Rota PA, Brown KE, Hübschen JM, Muller CP, Icenogle J, Chen MH, Bankamp B, Kessler JR, Brown DW, Bellini WJ, Featherstone D. Improving global virologic surveillance for measles and rubella. J Infect Dis. 2011 Jul;204 Suppl 1:S506-13. doi:10.1093/infdis/jir117. PMID:21666207.

Usonis V, Anca I, André F, Chlibek R, Cižman M, Ivaskeviciene I, Mangarov A, Mészner Z, Perenovska P, Pokorn M, Prymula R, Richter D, Salman N, Simurka P, Tamm E, Tešović G, Urbančíková I. Rubella revisited: where are we on the road to disease elimination in Central Europe? Vaccine. 2011 Nov 15;29(49):9141-7. doi:10.1016/j.vaccine.2011.09.104. PMID:21971445.

Zimmerman L, Rogalska J, Wannemuehler KA, Haponiuk M, Kosek A, Pauch E, Plonska E, Veltze D, Czarkowski MP, Buddh N, Reef S, Stefanoff P. Toward rubella elimination in Poland: need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts. J Infect Dis. 2011 Jul;204 Suppl 1:S389-95. doi:10.1093/infdis/jir082. PMID:21666189.

Zimmerman LA, Muscat M, Jankovic D, Goel A, Bang H, Khetsuriani N, Martin R. Status of rubella and congenital rubella syndrome surveillance, 2005-2009, the World Health Organization European Region. J Infect Dis. 2011 Jul;204 Suppl 1:S381-8. doi:10.1093/infdis/jir104. PMID:21666188.

Bechini A, Boccalini S, Tiscione E, Pesavento G, Mannelli F, Peruzzi M, Rapi S, Mercurio S, Bonanni P. Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile. Eur J Public Health. 2012 Feb;22(1):133-9. doi:10.1093/eurpub/ckq134. PMID:20880991.

Calimeri S, Capua A, La Fauci V, Squeri R, Grillo OC, Lo Giudice D. Prevalence of serum anti-rubella virus antibodies among pregnant women in southern Italy. Int J Gynaecol Obstet. 2012 Mar;116(3):211-3. doi:10.1016/j.ijgo.2011.10.029. PMID:22233835.

Goodson JL, Chu SY, Rota PA, Moss WJ, Featherstone DA, Vijayaraghavan M, Thompson KM, Martin R, Reef S, Strebel PM. Research priorities for global measles and rubella control and eradication. Vaccine. 2012 Jul 6;30(32):4709-16. doi:10.1016/j.vaccine.2012.04.058. PMID:22549089.

Metcalf CJ, Lessler J, Klepac P, Cutts F, Grenfell BT. Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination. Epidemiol Infect. 2012 Dec;140(12):2290-301. doi:10.1017/S0950268812000131. PMID:22335852.

Song N, Gao Z, Wood JG, Hueston L, Gilbert GL, MacIntyre CR, Quinn HE, Menzies R, McIntyre P. Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination. Vaccine. 2012 Jun 8;30(27):4073-8. doi:10.1016/j.vaccine.2012.04.025. PMID:22554644.

Tkadlecová H, Šviráková D, Macko J, Bartoníková N, Beneš Č, Zelená H, Pomiklová M, Vidličková I, Kováčiková Z. [Congenital rubella syndrome - case report]. Epidemiol Mikrobiol Imunol. 2012 Dec;61(4):98-102. PMID:23301624.

Barrabeig I, Torner N, Martínez A, Carmona G, Ciruela P, Batalla J, Costa J, Hernández S, Salleras L, Domínguez A; Rubella Surveillance Group of Catalonia. Results of the rubella elimination program in Catalonia (Spain), 2002-2011. Hum Vaccin Immunother. 2013 Mar;9(3):642-8. PMID:23299566.

Bechini A, Levi M, Boccalini S, Tiscione E, Panatto D, Amicizia D, Bonanni P. Progress in the elimination of measles and congenital rubella in Central Italy. Hum Vaccin Immunother. 2013 Mar;9(3):649-56. PMID:23292174.

Buffolano W, Filia A, Agnese M, Stronati M, Dicostanzo P. [Update for the standard procedures of diagnosis and therapy in cases of congenital rubella]. Pediatr Med Chir. 2013 May-Jun;35(3):110-7. PMID:23947110.

Centers for Disease Control and Prevention (CDC). Rubella and congenital rubella syndrome control and elimination - global progress, 2000-2012. MMWR Morb Mortal Wkly Rep. 2013 Dec 6;62(48):983-6. PMID:24304830.

Cutts FT, Lessler J, Metcalf CJ. Measles elimination: progress, challenges and implications for rubella control. Expert Rev Vaccines. 2013 Aug;12(8):917-32. doi:10.1586/14760584.2013.814847. PMID:23984961.

Mongua-Rodriguez N, Díaz-Ortega JL, García-García L, Piña-Pozas M, Ferreira-Guerrero E, Delgado-Sánchez G, Ferreyra-Reyes L, Cruz-Hervert LP, Baez-Saldaña R, Campos-Montero R. A systematic review of rubella vaccination strategies implemented in the Americas: impact on the incidence and seroprevalence rates of rubella and congenital rubella syndrome. Vaccine. 2013 Apr 19;31(17):2145-51. doi:10.1016/j.vaccine.2013.02.047. PMID:23470237.

O'Dwyer V, Bonham S, Mulligan A, O'Connor C, Farah N, Kennelly MM, Turner MJ. Antenatal rubella immunity in Ireland. Ir Med J. 2013 Sep;106(8):232-5. PMID:24282891.

Paradowska-Stankiewicz I, Czarkowski MP, Derrough T, Stefanoff P. Ongoing outbreak of rubella among young male adults in Poland: increased risk of congenital rubella infections. Euro Surveill. 2013 May 23;18(21). PMID:23725976.

Grangeot-Keros L, Bouthry E, Vauloup-Fellous C. [Rubella: a current issue?]. Presse Med. 2014 Jun;43(6 Pt 1):698-705. doi:10.1016/j.lpm.2013.10.009. PMID:24785141.

Yamada T, Mochizuki J, Hanaoka M, Hashimoto E, Ohkuchi A, Ito M, Kubo T, Nakai A, Saito S, Unno N, Matsubara S, Minakami H. Effects of campaign for postpartum vaccination on seronegative rate against rubella among Japanese women. BMC Infect Dis. 2014 Mar 21;14:152. doi:10.1186/1471-2334-14-152. PMID:24650141.

Khandaker G, Zurynski Y, Jones C. Surveillance for congenital rubella in Australia since 1993: cases reported between 2004 and 2013. Vaccine. 2014 Nov 28;32(50):6746-51. doi:10.1016/j.vaccine.2014.10.021. PMID:25454858.

Lo Giudice D, Capua A, La Fauci V, Squeri R, Grillo OC, Calimeri S. Congenital rubella syndrome and immunity status of immigrant women living in southern Italy: a cross-sectional, seroepidemiological investigation. Travel Med Infect Dis. 2014 May-Jun;12(3):253-7. doi:10.1016/j.tmaid.2014.01.003. PMID:24502919.

Morioka I, Sonoyama A, Tairaku S, Ebina Y, Nagamata S, Morizane M, Tanimura K, Iijima K, Yamada H. Awareness of and knowledge about mother-to-child infections in Japanese pregnant women. Congenit Anom (Kyoto). 2014 Feb;54(1):35-40. doi:10.1111/cga.12030. PMID:24588778.

Chan J, Dey A, Wang H, Martin N, Beard F. Australian vaccine preventable disease epidemiological review series: rubella 2008-2012. Commun Dis Intell Q Rep. 2015 Mar 31;39(1):E19-26. PMID:26063094.

Cozza V, Martinelli D, Cappelli MG, Tafuri S, Fortunato F, Prato R. Further efforts in the achievement of congenital rubella syndrome/rubella elimination. Hum Vaccin Immunother. 2015;11(1):220-4. doi:10.4161/hv.36154. PMID:25483539.

Giambi C, Montaño-Remacha C, Celentano LP, Derrough T; national focal points for rubella. Surveillance of congenital rubella and rubella infections in pregnancy in EU/EEA countries, 2012: Current status and future perspective to monitor elimination. Vaccine. 2015 Sep 11;33(38):4929-37. doi:10.1016/j.vaccine.2015.07.041. PMID:26209837.

Giambi C, Filia A, Rota MC, Del Manso M, Declich S, Nacca G, Rizzuto E, Bella A; regional contact points for rubella. Congenital rubella still a public health problem in Italy: analysis of national surveillance data from 2005 to 2013. Euro Surveill. 2015 Apr 23;20(16). PMID:25953272.

Jyoti M, Shirke S, Matalia H. Congenital rubella syndrome: Global issue. J Cataract Refract Surg. 2015 May;41(5):1127. doi:10.1016/j.jcrs.2015.04.021. PMID:26049858.

Martínez-Quintana E, Castillo-Solórzano C, Torner N, Rodríguez-González F. Congenital rubella syndrome: a matter of concern. Rev Panam Salud Publica. 2015 Mar;37(3):179-86. PMID:25988255.

Masa Calles J, López Perea N, Torres de Mier Mde V. [Epidemiologic Surveillance on Measles, Rubella and Congenital Rubella Syndrome. Spain]. Rev Esp Salud Publica. 2015 Jul-Aug;89(4):365-79. doi:10.4321/S1135-57272015000400005. PMID:26580792.

Neu N, Duchon J, Zachariah P. TORCH infections. Clin Perinatol. 2015 Mar;42(1):77-103, viii. doi:10.1016/j.clp.2014.11.001. PMID:25677998.

Plans P, de Ory F, Campins M, Álvarez E, Payà T, Guisasola E, Compte C, Vellbé K, Sánchez C, Lozano MJ, Aran I, Bonmatí A, Carreras R, Jané M, Cabero L. Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013. Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1161-71. doi:10.1007/s10096-015-2339-4. PMID:25666082.

Sugishita Y, Shimatani N, Katow S, Takahashi T, Hori N. Epidemiological characteristics of rubella and congenital rubella syndrome in the 2012-2013 epidemics in Tokyo, Japan. Jpn J Infect Dis. 2015;68(2):159-65. doi:10.7883/yoken.JJID.2014.195. PMID:25672351.

Vilajeliu A, García-Basteiro AL, Valencia S, Barreales S, Oliveras L, Calvente V, Goncé A, Bayas JM. Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain. Vaccine. 2015 Apr 8;33(15):1767-72. doi:10.1016/j.vaccine.2015.02.043. PMID:25731790.

Kinoshita R, Nishiura H. Assessing herd immunity against rubella in Japan: a retrospective seroepidemiological analysis of age-dependent transmission dynamics. BMJ Open. 2016 Jan 27;6(1):e009928. doi:10.1136/bmjopen-2015-009928. PMID:26817640.

Ogundele M, Ghebrehewet S, Chawla A. Some factors affecting rubella seronegative prevalence among pregnant women in a North West England region between April 2011 and March 2013. J Public Health (Oxf). 2016 Jun;38(2):243-9. doi:10.1093/pubmed/fdv033. PMID:25788714.

Paradowska-Stankiewicz I, Rogalska J, Polkowska A. Rubella in Poland in 2014. Przegl Epidemiol. 2016;70(3):341-348. PMID:27854416.

Vynnycky E, Adams EJ, Cutts FT, Reef SE, Navar AM, Simons E, Yoshida LM, Brown DW, Jackson C, Strebel PM, Dabbagh AJ. Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review. PLoS One. 2016 Mar 10;11(3):e0149160. doi:10.1371/journal.pone.0149160. PMID: 26962867.

Mori Y, Miyoshi M, Kikuchi M, Sekine M, Umezawa M, Saikusa M, Matsushima Y, Itamochi M, Yasui Y, Kanbayashi D, Miyoshi T, Akiyoshi K, Tatsumi C, Zaitsu S, Kadoguchi M, Otsuki N, Okamoto K, Sakata M, Komase K, Takeda M. Molecular Epidemiology of Rubella Virus Strains Detected Around the Time of the 2012-2013 Epidemic in Japan. Front Microbiol. 2017 Aug 9;8:1513. doi:10.3389/fmicb.2017.01513. PMID:28848523.

Baltimore RS, Nimkin K, Sparger KA, Pierce VM, Plotkin SA. Case 4-2018: A Newborn with Thrombocytopenia, Cataracts, and Hepatosplenomegaly. N Engl J Med. 2018 Feb 8;378(6):564-572. doi:10.1056/NEJMcpc1706110. PMID:29414276.

Bukasa A, Campbell H, Brown K, Bedford H, Ramsay M, Amirthalingam G, Tookey P. Rubella infection in pregnancy and congenital rubella in United Kingdom, 2003 to 2016. Euro Surveill. 2018 May;23(19). doi:10.2807/1560-7917.ES.2018.23.19.17-00381. PMID:29766840.

Edirisuriya C, Beard FH, Hendry AJ, Dey A, Gidding HF, Hueston L, Dwyer DE, Wood JG, Macartney KK, McIntyre PB. Australian rubella serosurvey 2012-2013: On track for elimination? Vaccine. 2018 May 11;36(20):2794-2798. doi:10.1016/j.vaccine.2018.03.086. Epub 2018 Apr 13. PMID:29661586.

Meng Q, Luo J, Li L, Shi W, Yu J, Shen Y, Li L, Wang Y, Yao K. Rubella seroprevalence among pregnant women in Beijing, China. BMC Infect Dis. 2018 Mar 15;18(1):130. doi:10.1186/s12879-018-3032-x. PMID:29544450.

Pettinicchio V, Santoro V, Vazzoler C, Magliocchetti P, Orsini D, Lancia A, Franco E. Voluntary termination of pregnancy: An opportunity for Measles, Mumps and Rubella vaccination in an Italian healthcare local unit. Hum Vaccin Immunother. 2018 Apr 3;14(4):864-867. doi:10.1080/21645515.2017.1409317. PMID:29261361.

Seppälä EM, López-Perea N, Torres de Mier MV, Echevarría JE, Fernández-García A, Masa-Calles J. Last cases of rubella and congenital rubella syndrome in Spain, 1997-2016: The success of a vaccination program. Vaccine. 2019 Jan 3;37(1):169-175. doi: 10.1016/j.vaccine.2018.11.017. PMID: 30454948.

World Bank Available at: http://datatopics.worldbank.org/world-development-indicators/the-world-by-income-and-region.html. Accessed on 15/05/2019.

Maurici M, Dugo V, Zaratti L, Paulon L, Pellegrini MG, Baiocco E, Rizzo G, Franco E. Knowledge and attitude of pregnant women toward flu vaccination: a cross-sectional survey. J Matern Fetal Neonatal Med. 2016 Oct;29(19):3147-50. doi: 10.3109/14767058.2015.1118033.

EpiCentro - Portale di epidemiologia. La sorveglianza Passi. Vaccinazione antirosolia. Roma: Istituto Superiore di Sanità. Available at: http://www.epicentro.iss.it/passi/dati/VaccinazioneAntirosolia.asp ultima consultazione 22/10/2018. Accessed on 30/10/2018.

Vynnycky E, Papadopoulos T, Angelis K. The impact of Measles-Rubella vaccination on the morbidity and mortality from Congenital Rubella Syndrome in 92 countries. Hum Vaccin Immunother. 2018 Oct 4:1-8. doi:10.1080/21645515.2018.1532257. PMID: 30285537.

McElroy R, Laskin M, Jiang D, Shah R, Ray JG. Rates of rubella immunity among immigrant and non-immigrant pregnant women. J Obstet Gynaecol Can. 2009 May;31(5):409-13.

Miyoshi M, Komagome R, Ishida S, Nagano H, Okano M. Epidemiology and laboratory diagnoses of rubella in Hokkaido district during the Nationwide Outbreak in Japan, 2011-2013. Jpn J Infect Dis. 2014;67(6):479-84. PMID:25410565.

Tipples GA. Rubella diagnostic issues in Canada. J Infect Dis. 2011 Sep 1;204 Suppl 2:S659-63. doi: 10.1093/infdis/jir430. PMID: 21954263.

Abrams S, Kourkouni E, Sabbe M, Beutels P, Hens N. Inferring rubella outbreak risk from seroprevalence data in Belgium. Vaccine. 2016 Dec 7;34(50):6187-6192. doi: 10.1016/j.vaccine.2016.10.072. PMID: 27840011.

Roadmap to elimination standard measles and rubella surveillance. Wkly Epidemiol Rec. 2017 Mar 3;92(9-10):97-105. PMID:28262010.

Motaze NV, Manamela J, Smit S, Rabie H, Harper K, duPlessis N, Reubenson G, Coetzee M, Ballot D, Moore D, Nuttall J, Linley L, Tooke L, Kriel J, Hallbauer U, Sutton C, Moodley P, Hardie D, Mazanderani AH, Goosen F, Kyaw T, Leroux D, Hussain A, Singh R, Kelly C, Ducasse G, Muller M, Blaauw M, Hamese M, Leeuw T, Mekgoe O, Rakgole P, Dungwa N, Maphosa T, Sanyane K, Preiser W, Cohen C, Suchard M. Congenital rubella syndrome surveillance in South Africa using a sentinel site approach: a cross-sectional study. Clin Infect Dis. 2018 Sep 8. doi:10.1093/cid/ciy758. PMID: 30203002.

Desjardins M, Boucoiran I, Paquet C, Laferrière C, Gosselin-Brisson A, Labbé AC, Martel-Laferrière V. Impact of Vaccination History on Serological Testing in Pregnant Women. J Obstet Gynaecol Can. 2018 Apr;40(4):405-409.

Boucoiran I, Castillo E. No. 368-RUBELLA IN PREGNANCY. J Obstet Gynaecol Can.2018 Dec;40(12):1646-1656.

A. Christie. The mirror crack’d from side to side. 1962